Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Within-patient variability in tacrolimus pharmacokinetics with different tacrolimus formulations in renal transplant patients
2015-005559-29Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Apr 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in kidney transplant (3 arms), sponsored by Erasmus MC. Primary endpoint: Intra-patient variability of tacrolimus pharmacokinetics across formulations. Started Apr 2016; status: active.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2015-005559-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005559-29.